Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
USI Insurance Services Claims Ex-Broker Poached Clients for Own New Agency 
AI Savings Misses ‘Should Be Making Executives Uncomfortable,’ Bain Says 
Acrisure Goes After Former Owners of Businesses it Acquired for Leaving to Compete 
AIG’s Turnaround Under Zaffino Sets Stage for New Leadership 
